LightPath Technologies
LPTH
10.23
-0.17
-1.63%
LightPath Technologies
US · LPTH
#3483 by market cap
10.23
-0.17
-1.63%
Live - 5344 symbols - heartbeat 126s ago
· 2026-10-08 10:11
Pre-market
10.16
-2.31%
After-hours
10.46
+0.58%
Overnight
10.30
-0.96%
- Market cap
- 716.47M
- P/E (TTM)i
- -26.92
- P/Bi
- 4.79
- EPSi
- -0.38
- Div yieldi
- 0.00%
- 52W posi
- 34%
Reader sentiment
Are you bullish or bearish on LPTH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.77, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +92.79% YoY
Margins
- Gross margin
- 35.98%
- Operating margin
- -6.24%
- Net margin
- -28.65%
Key ratios & quality
- Enterprise valuei
- 624.91M
- Altman Z-Scorei
- 8.77
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.75M | 34.97M | 38.46M | 35.56M | 32.93M | 31.73M | 37.20M | 71.72M |
| Gross profit | 12.52M | 13.84M | 13.45M | 11.81M | 11.07M | 8.63M | 10.13M | 25.80M |
| Selling & admin expenses | 10.50M | 8.96M | 11.99M | 11.22M | 11.44M | 12.30M | 15.81M | 24.66M |
| Research & development | 2.02M | 1.71M | 2.17M | 2.09M | 2.15M | 2.40M | 3.06M | 3.78M |
| Operating profit | -1.22M | 2.04M | -1.83M | -2.62M | -3.63M | -7.70M | -10.16M | -4.47M |
| Pretax profit | -2.23M | 1.63M | -2.25M | -2.68M | -3.81M | -7.94M | -14.84M | -20.23M |
| Tax | 455.21K | 764.00K | 933.92K | 862.91K | 234.03K | 67.49K | 37.79K | 314.71K |
| Net profit | -2.68M | 866.93K | -3.19M | -3.54M | -4.05M | -8.01M | -14.87M | -20.55M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.10 | 0.03 | -0.12 | -0.13 | -0.13 | -0.21 | -0.36 | -0.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 9.17M | 12.21M | 15.06M | 16.35M | 19.15M | 21.16M |
| Gross profit | 2.66M | 2.69M | 4.48M | 6.02M | 6.96M | 8.35M |
| Selling & admin expenses | 4.45M | 4.74M | 4.38M | 5.86M | 6.30M | 8.12M |
| Research & development | 757.94K | 1.06M | 867.43K | 748.83K | 1.04M | 1.13M |
| Operating profit | -3.32M | -3.06M | -1.22M | -1.04M | -859.04K | -1.36M |
| Pretax profit | -3.48M | -7.18M | -2.81M | -9.37M | -4.01M | -4.03M |
| Tax | 100.03K | -122.40K | 81.27K | 30.56K | 91.39K | 111.50K |
| Net profit | -3.58M | -7.06M | -2.89M | -9.41M | -4.11M | -4.14M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.09 | -0.16 | -0.07 | -0.20 | -0.07 | -0.06 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 19.61M | 21.26M | 20.70M | 18.17M | 21.76M | 15.54M | 28.37M | 129.90M |
| Cash & ST investments | 4.60M | 5.39M | 6.77M | 5.51M | 4.69M | 3.48M | 4.88M | 93.20M |
| Inventory | 7.68M | 8.98M | 8.66M | 6.99M | 7.41M | 6.55M | 12.86M | 18.01M |
| Total assets | 45.97M | 47.57M | 54.61M | 50.71M | 53.54M | 48.09M | 81.51M | 194.01M |
| Total current liabilities | 6.36M | 7.40M | 8.45M | 7.73M | 6.83M | 8.04M | 17.10M | 26.18M |
| Short-term debt | 985.77K | 2.02M | 1.65M | 2.02M | 2.10M | 1.45M | 1.63M | 1.57M |
| Long-term debt | 5.00M | 4.44M | 4.06M | 3.22M | 1.55M | 325.88K | 4.80M | 74.88K |
| Total liabilities | 12,514,054.00 | 13,007,977.00 | 21,033,505.00 | 20,982,683.00 | 17,583,659.00 | 17,887,299.00 | 65,860,998.00 | 44,534,824.00 |
| Total equity | 33.46M | 34.57M | 33.58M | 29.73M | 35.95M | 30.20M | 15.64M | 149.47M |
| Retained earnings | -197.93M | -197.06M | -200.25M | -203.79M | -207.84M | -215.84M | -230.72M | -251.26M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 28.08M | 28.37M | 35.16M | 97.00M | 83.00M | 129.90M |
| Cash & ST investments | 6.48M | 4.88M | 11.51M | 73.57M | 55.24M | 93.20M |
| Inventory | 12.69M | 12.86M | 12.86M | 13.49M | 13.34M | 18.01M |
| Total assets | 81.42M | 81.51M | 87.26M | 148.56M | 144.27M | 194.01M |
| Total current liabilities | 12.23M | 17.10M | 17.75M | 24.42M | 21.53M | 26.18M |
| Short-term debt | 1.66M | 1.63M | 1.69M | 1.68M | 1.56M | 1.57M |
| Long-term debt | 4.69M | 4.80M | 4.87M | 135.07K | 103.66K | 74.88K |
| Total liabilities | 65,696,416.00 | 65,860,998.00 | 65,822,432.00 | 70,623,420.00 | 55,175,502.00 | 44,534,824.00 |
| Total equity | 15.72M | 15.64M | 21.44M | 77.94M | 89.09M | 149.47M |
| Retained earnings | -223.66M | -230.72M | -233.61M | -243.02M | -247.12M | -251.26M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 411.19K | 3.73M | 4.73M | 1.46M | -2.81M | 521.04K | -8.33M | -10.23M |
| Depreciation & amortization | 3.46M | 3.42M | 3.51M | 3.62M | 3.17M | 4.05M | 4.15M | 5.04M |
| Free cash flow | -1.52M | 1.29M | 1.57M | -162.49K | -5.89M | -1.66M | -9.59M | -16.49M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | 9.20M | 806.33K | 437.73K | 120.23M |
| Ending cash balance | 4.60M | 5.39M | 6.77M | 5.51M | 7.14M | 3.48M | 4.88M | 93.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -3.24M | -2.65M | -1.14M | 2.82M | -6.80M | -5.11M |
| Depreciation & amortization | 1.46M | 792.49K | 1.22M | 1.24M | 1.26M | 1.32M |
| Free cash flow | -3.66M | -3.33M | -1.22M | 1.96M | -7.70M | -9.53M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 437.73K | 0 | 7.89M | 65.34M | -98.29K | 47.09M |
| Ending cash balance | 6.48M | 4.88M | 11.51M | 73.57M | 55.24M | 93.20M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -7.79 | 2.55 | -9.35 | -11.19 | -12.32 | -24.21 | -64.89 | -24.89 |
| ROA %i | -5.76 | 1.85 | -6.23 | -6.73 | -7.76 | -15.76 | -22.95 | -14.91 |
| ROIC %i | -5.24 | 2.71 | -6.73 | -7.31 | -8.27 | -17.69 | -39.34 | -21.49 |
| 5-year avg ROE %i | 7.79 | 10.17 | 5.31 | -4.50 | -7.62 | -10.90 | -24.39 | -27.50 |
| EBIT margin %i | -4.53 | 5.63 | -5.29 | -6.89 | -10.72 | -24.42 | -36.87 | -6.24 |
| FCF / sales %i | -- | 3.69 | 4.09 | -- | -- | -- | -- | -- |
| Current ratioi | 3.09 | 2.87 | 2.45 | 2.35 | 3.18 | 1.93 | 1.66 | 4.96 |
| Quick ratioi | 1.76 | 1.58 | 1.37 | 1.39 | 1.66 | 1.05 | 0.84 | 4.14 |
| Debt / assetsi | 14.41 | 16.04 | 26.06 | 29.04 | 23.13 | 21.54 | 18.63 | 5.63 |
| LT debt / equityi | 16.86 | 16.21 | 37.48 | 42.74 | 28.61 | 29.51 | 86.63 | 6.26 |
| Interest coveragei | -2.19 | 5.80 | -9.45 | -10.68 | -12.46 | -40.38 | -12.27 | -- |
| Revenue CAGR (3Y) %i | 25.02 | 7.22 | 5.75 | 1.76 | -1.98 | -6.22 | 1.52 | 29.62 |
| Net income CAGR (3Y) %i | -- | -51.72 | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -22.54 | 149.49 | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -42.89 | -64.89 | -63.45 | -43.84 | -44.77 | -24.89 |
| ROA %i | -15.51 | -22.95 | -23.79 | -23.60 | -20.79 | -14.91 |
| ROIC %i | -26.31 | -39.34 | -38.52 | -34.43 | -35.42 | -21.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -27.41 | -36.87 | -33.75 | -40.72 | -36.30 | -6.24 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.30 | 1.66 | 1.98 | 3.97 | 3.86 | 4.96 |
| Quick ratioi | 1.16 | 0.84 | 1.19 | 3.36 | 3.07 | 4.14 |
| Debt / assetsi | 17.60 | 18.63 | 17.61 | 6.91 | 7.85 | 5.63 |
| LT debt / equityi | 80.57 | 86.63 | 63.81 | 11.01 | 10.96 | 6.26 |
| Interest coveragei | -10.87 | -12.27 | -11.96 | -15.88 | -38.28 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Assemblies and modules is the largest reported line at 44.45% of revenue, across 4 reported segments.
- No single line clears half of revenue; Infrared components is next at 29.55%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Assemblies and modules44.45%
Infrared components29.55%
Visible components21.60%
Engineering services4.40%
Region
United States51.64%
United Kingdom20.91%
Israel10.74%
Other European Countries6.49%
China6.31%
Other Asian countries2.55%
Rest of world1.36%
Quote time 2026-10-08 10:11:00 · For reference only, not investment advice and not tailored to your situation.